Higher price of Covaxin in private markets needed to sustain costs: Bharat Biotech

Supply to the government of India at ₹150 per dose is a non-competitive price and clearly not sustainable in the long run, the company said

Comments

Popular posts from this blog

MUDA scam: Karnataka Lokayukta seeks more time to submit final report

Kannada actor held for smuggling gold worth Rs 12 cr from Dubai

Rahul Dravid’s car hit by goods-laden auto in Bengaluru, video goes viral